logo

Indian News

Share

pharma-september-092118.jpg Clinical trial data is an important catalyst, and any update on the clinical studies can send the biotech/pharma stocks soaring or stumbling depending upon the news. Now, here are some of the pharma/biotech stocks to watch out for in the week starting September 24.

pharma-032717_20sep18.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

pharma-032118_20sep18.jpg The following are some of today's top gainers in the pharma/biotech sector.

antarecpharma-sept20.jpg Shares of Antares Pharma Inc. (ATRS) have lost nearly 7% of their value so far this month, as the company's regulatory catalyst draws closer. Antares Pharma is a revenue-generating, specialty pharmaceutical company, focusing on self-injection pharmaceutical products and technologies, and topical gel-based products.

Follow RTT